Breast cancer drug can suppress brain seizures

New York, May 13 (IANS) A class of drug that inhibits production of the primary female sex hormone, estrogen, and is used to treat breast cancer has been found to quickly and effectively suppress dangerous brain seizures, a study says.

“The effect was profound and very clear,” said Catherine Woolley, senior author of the study from Northwestern University in Evanston, Illinois.

The research was conducted in a rat model of status epilepticus, a condition characterised by a prolonged episode of seizure activity.

“This shows that clinically available drugs could be effective therapies for suppressing seizures in humans,” Woolley noted.

The researchers also discovered, to their surprise, that seizures stimulate the production of estrogens in the brain of both males and females and that this plays a previously unknown role in the escalation of seizure activity.

Estrogen synthesis during a seizure makes it worse, the study found.

The findings suggest a new approach to treating seizures in humans — shut down the brain’s production of estrogen when a seizure first begins.

Current seizure treatments are not targeted. They work by dampening neural activity generally and come with many side effects, such as drowsiness, dizziness or difficulty concentrating.

In the study published in the journal eLife, the researchers found that inhibiting estrogen synthesis just after seizure onset strongly suppressed seizures in both sexes, without anti-seizure drugs or other interventions.

The scientists injected male and female animals with either an inert substance or an aromatase inhibitor, either letrozole or fadrozole, just after the start of a chemically induced seizure.

They studied the animals for up to six hours and found both fadrozole and letrozole strongly suppressed seizures in both sexes.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of or any employee thereof. is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here